Search research articles
Contact Us
Filters
Showing results (181-190 of 206) with videos related to
Page
of 21
Sort By:
British Journal of Clinical Pharmacology
|
October 21, 2024
Single-dose and steady-state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug-drug interaction study
Amelie Leutzendorff, Valentin Al Jalali, Martin Bauer, et al.
Molecular Pharmaceutics
|
September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in Mice
Martin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Artificial Organs
|
November 25, 2010
The role of phospho-adenosine monophosphate-activated protein kinase and vascular endothelial growth factor in a model of chronic heart failure
Florian Heidrich, Samuel Sossalla, Hanna Schotola, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in Humans
Nicolas Tournier, Martin Bauer, Verena Pichler, et al.
Epilepsia
|
May 9, 2007
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil
Oliver Langer, Martin Bauer, Alexander Hammers, et al.
Frontiers in Immunology
|
April 2, 2021
Activation of Neutrophil Granulocytes by Platelet-Activating Factor Is Impaired During Experimental Sepsis
Stefan Hug, Stefan Bernhard, Alexander Elias Paul Stratmann, et al.
Fluids and Barriers of the CNS
|
October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patients
Myriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science
|
May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier
Myriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
European Journal of Clinical Pharmacology
|
May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9
Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, et al.
Clinical Pharmacology and Therapeutics
|
September 24, 2017
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography
Martin Bauer, Akihiro Matsuda, Beatrix Wulkersdorfer, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 206) with videos related to
Sort By:
Page
of 21
British Journal of Clinical Pharmacology
|
October 21, 2024
Single-dose and steady-state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug-drug interaction study
Amelie Leutzendorff, Valentin Al Jalali, Martin Bauer, et al.
Molecular Pharmaceutics
|
September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in Mice
Martin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Artificial Organs
|
November 25, 2010
The role of phospho-adenosine monophosphate-activated protein kinase and vascular endothelial growth factor in a model of chronic heart failure
Florian Heidrich, Samuel Sossalla, Hanna Schotola, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in Humans
Nicolas Tournier, Martin Bauer, Verena Pichler, et al.
Epilepsia
|
May 9, 2007
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil
Oliver Langer, Martin Bauer, Alexander Hammers, et al.
Frontiers in Immunology
|
April 2, 2021
Activation of Neutrophil Granulocytes by Platelet-Activating Factor Is Impaired During Experimental Sepsis
Stefan Hug, Stefan Bernhard, Alexander Elias Paul Stratmann, et al.
Fluids and Barriers of the CNS
|
October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patients
Myriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science
|
May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier
Myriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
European Journal of Clinical Pharmacology
|
May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9
Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, et al.
Clinical Pharmacology and Therapeutics
|
September 24, 2017
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography
Martin Bauer, Akihiro Matsuda, Beatrix Wulkersdorfer, et al.
Page
of 21